Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1001233 · SGMOQ

Sangamo Therapeutics, Inc

Filing with the SEC — securities delisted SEC-reporting company Richmond, CA OTC
An email when it files something new with the SEC. Your account

What this means

  • Bankruptcy or receivership reportedThe company reported a bankruptcy or receivership under Item 1.03 of Form 8-K on Sep 21, 2026. Creditors file claims with the bankruptcy court; the docket is on PACER.
  • Securities removed from an exchangeA Form 25-NSE filed on Oct 7, 2026 removes a class of the company’s securities from listing (Removed from Nasdaq Stock Market). It can concern shares, warrants, notes or units — check the form for the class.
  • Quarterly report lateOn Aug 17, 2026 the company filed Form NT 10-Q: it could not file its quarterly report on time. Rule 12b-25 gives an extra 15 calendar days for an annual report and 5 for a quarterly report. We have no later report from the company yet.
  • Change of auditorOn Jul 1, 2026 the company reported a change of its independent accountant (Item 4.01). The 8-K must say whether there were disagreements with the former auditor.
  • RestructuringOn Jun 23, 2026 the company committed to an exit or disposal plan with material costs (Item 2.05).
  • Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$14.3M (XBRL data filed with the SEC).
  • Net loss in 2025Net loss of $123M for the year (2024: −$97.9M).
  • Revenue downRevenue fell from $57.8M in 2024 to $39.6M in 2025 (32% lower).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$39.6M$57.8M
Net income (loss)−$123M−$97.9M
Total assets$59.7M$102M
Total liabilities$74M$78.9M
Stockholders’ equity−$14.3M$22.8M
Cash and equivalents$20.9M$41.9M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
SANGAMO THERAPEUTICS, INC
Formerly: Sangamo Biosciences Inc
CIK
0001001233
Tickers
SGMOQ
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC — securities delisted
State of incorporation
Delaware
Business address
Richmond, California
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Mar 31, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 7, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Delisted by the exchange (Form 25-NSE): Removed from Nasdaq Stock Market
    Form 25-NSE · filed Oct 7, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.03, 2.01, 9.01 · filed Sep 21, 2026 · filing
  • Bankruptcy or receivership
    Form 8-K · items 1.03, 2.01, 9.01 · filed Sep 21, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.03, 2.01, 7.01, 9.01 · filed Sep 8, 2026 · filing
  • Bankruptcy or receivership
    Form 8-K · items 1.03, 2.01, 7.01, 9.01 · filed Sep 8, 2026 · filing
  • Bankruptcy or receivership
    Form 8-K · items 1.01, 1.03, 9.01 · filed Aug 28, 2026 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Aug 17, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 1.03, 3.01 · filed Jul 20, 2026 · filing
  • Bankruptcy or receivership
    Form 8-K · items 1.03, 3.01 · filed Jul 20, 2026 · filing
  • Change of auditor
    Form 8-K · items 4.01, 8.01, 9.01 · filed Jul 1, 2026 · filing
  • Restructuring or layoffs
    Form 8-K · items 1.01, 1.03, 2.03, 2.05 · filed Jun 23, 2026 · filing
  • Bankruptcy or receivership
    Form 8-K · items 1.01, 1.03, 2.03, 2.05 · filed Jun 23, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Apr 29, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 30, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 30, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02 · filed Feb 3, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02 · filed Feb 3, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Oct 29, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 30, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 11, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 7, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 7, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 16, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 12, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed May 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 17, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 17, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 6, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 5.07, 9.01 · filed Jun 5, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 9, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Apr 30, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 13, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 13, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 19, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 1, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 1, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 8, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 8, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 5.07 · filed Jun 2, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 8, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 2.05, 5.02, 9.01 · filed Apr 26, 2023 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.02, 2.05, 5.02, 9.01 · filed Apr 26, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 2.05, 5.02, 9.01 · filed Apr 26, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Feb 23, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 22, 2023 · filing